Delta-sleep-inducing peptide is a neuropeptide that affects a number of endocrine and physiological processes within the central nervous system. DSIP is of primary interest for its abilities to reduce oxidative stress, normalize myocardial contractility. It is also being studied as a potential target in the treatment of major depressive disorder.
 
THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.
 
Treatment and prevention of stress-induced conditions
Alcohol withdrawal syndrome and primary pathological craving for alcohol
Quantity: 5 mg
Purity: over 97%
Form: lyophilizate
Excipient: mannitol
Storage: no more than +5C
Amino acid sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
Primary area of research: sleep improvement and recovery.
Molecular weight: 848.81
Molecular formula: C35H48N10O15